Carriers of pathogenic variants in the MLH1 and MSH2 genes are estimated to have a similarly high risk of developing CRC, MSH6 carriers have an intermediate risk on this genetic spectrum5, and PMS2 carriers a lower risk6. The gene discussed is MSH2; the disease is colorectal carcinoma.